Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Metabolic Signatures and Biomarkers
Metabolic Signatures and Biomarkers for Aripiprzole
Status: Enrolling
Updated:  4/25/2007
John Umstead Hospital
mi
from
Butner, NC
Metabolic Signatures and Biomarkers
Metabolic Signatures and Biomarkers for Aripiprzole
Status: Enrolling
Updated: 4/25/2007
John Umstead Hospital
mi
from
Butner, NC
Click here to add this to my saved trials
Metabolic Signatures and Biomarkers
Metabolic Signatures and Biomarkers for Aripiprzole
Status: Enrolling
Updated:  4/25/2007
Duke Univ Med Ctr
mi
from
Durham, NC
Metabolic Signatures and Biomarkers
Metabolic Signatures and Biomarkers for Aripiprzole
Status: Enrolling
Updated: 4/25/2007
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Self-Management Therapy for Youth With Schizophrenia
Self-Management Therapy for Youth With Schizophrenia
Status: Enrolling
Updated:  12/26/2007
Univ of Washington
mi
from
Seattle, WA
Self-Management Therapy for Youth With Schizophrenia
Self-Management Therapy for Youth With Schizophrenia
Status: Enrolling
Updated: 12/26/2007
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients
A Single-Center, Double-Blind, Placebo-Controlled, Randomized Blocks Study Investigating the Effect of 4 Dosages (1 mg, 5 mg, 15 mg, 50 mg) of MEM 3454 on P50 Sensory Gating and Mismatch Negativity (MMN) in Patients With Schizophrenia
Status: Enrolling
Updated:  7/30/2008
University of Colorado Health Sciences Center
mi
from
Denver, CO
A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients
A Single-Center, Double-Blind, Placebo-Controlled, Randomized Blocks Study Investigating the Effect of 4 Dosages (1 mg, 5 mg, 15 mg, 50 mg) of MEM 3454 on P50 Sensory Gating and Mismatch Negativity (MMN) in Patients With Schizophrenia
Status: Enrolling
Updated: 7/30/2008
University of Colorado Health Sciences Center
mi
from
Denver, CO
Click here to add this to my saved trials
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
Pimozide Augmentation of Clozapine in Schizophrenia
Status: Enrolling
Updated:  10/23/2008
Manhattan Psychiatric Center
mi
from
New York, NY
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
Pimozide Augmentation of Clozapine in Schizophrenia
Status: Enrolling
Updated: 10/23/2008
Manhattan Psychiatric Center
mi
from
New York, NY
Click here to add this to my saved trials
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
Pimozide Augmentation of Clozapine in Schizophrenia
Status: Enrolling
Updated:  10/23/2008
The Mount Sinai Hospital
mi
from
New York, NY
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
Pimozide Augmentation of Clozapine in Schizophrenia
Status: Enrolling
Updated: 10/23/2008
The Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
Pimozide Augmentation of Clozapine in Schizophrenia
Status: Enrolling
Updated:  10/23/2008
Pilgrim Psychiatric Center
mi
from
W. Brentwood, NY
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
Pimozide Augmentation of Clozapine in Schizophrenia
Status: Enrolling
Updated: 10/23/2008
Pilgrim Psychiatric Center
mi
from
W. Brentwood, NY
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Little Rock, AR
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Anaheim, CA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Cerritos, CA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Cerritos, CA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Costa Mesa, CA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Escondido, CA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Escondido, CA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Garden Grove, CA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Long Beach, CA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Los Angeles, CA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Oceanside, CA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Pasadena, CA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Pasadena, CA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Pico Rivera, CA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
San Diego, CA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Santa Ana, CA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
New Britain, CT
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
New Britain, CT
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
New Haven, CT
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Washington,
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Boca Raton, FL
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Coral Gables, FL
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
North Miami, FL
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
North Miami, FL
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Orlando, FL
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Tampa, FL
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Atlanta, GA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Augusta, GA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Marietta, GA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Chicago, IL
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Joliet, IL
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Joliet, IL
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Schaumburg, IL
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Schaumburg, IL
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Indianapolis, IN
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
New Orleans, LA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Glen Burnie, MD
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Glen Burnie, MD
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Haverhill, MA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Haverhill, MA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Pittsfield, MA
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Pittsfield, MA
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Minneapolis, MN
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
St. Louis, MO
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Las Vegas, NV
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Nashua, NH
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Nashua, NH
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Cherry Hill, NJ
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
mi
from
Clementon, NJ
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
mi
from
Clementon, NJ
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
East Orange, NJ
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
East Orange, NJ
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Newark, NJ
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Paramus, NJ
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Paramus, NJ
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Brooklyn, NY
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated:  11/21/2008
Clinical Research Facility
mi
from
Cedarhurst, NY
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia
Status: Enrolling
Updated: 11/21/2008
Clinical Research Facility
mi
from
Cedarhurst, NY
Click here to add this to my saved trials